cspc: China okays its first mRNA vaccine, from drugmaker CSPC
China has approved its first domestically developed mRNA vaccine against COVID-19, CSPC Pharmaceutical Group Ltd said on Wednesday, a major achievement in a...
Bird flu shots for humans: Why vaccine makers are keeping them ready
Vaccine makers are making bird flu vaccines for humans. Can humans get bird flu? Avian influenza H5N1 in humans .
Source link
UP drug controller cancels license of Marion Biotech in cough syrup adulteration
The UP Drug Controller has cancelled the license of the Noida-based Marion Biotech that manufactured the alleged contaminated cough syrup linked to the...
PM Modi to hold high-level review meeting on Covid situation
Amid an uptick in COVID-19 cases, Prime Minister Narendra Modi will hold a high-level meeting on Wednesday to review the situation and public...
Covid symptoms are similar to flu this time around
Many people who are sick from Covid-19 are not showing symptoms that are very different from that of the seasonal flu this time....
Consuming almonds before meal improves blood sugar levels: Study
A simple addition of a small portion of almonds before each meal can improve blood sugar levels in people with prediabetes, a first...
Gennova Biopharma seeks DCGI nod for its Omicron booster
Gennova Biopharmaceuticals, subsidiary of Pune-based drugmaker Emcure has submitted data for its mRNA-based Omicron specific Covid-19 booster shot for authorisation to the drug...
Sevenhills Healthcare: Sevenhills Hospital RP seeks repossession of hospital from civic body
The resolution professional of Sevenhills Healthcare, the hospital where superstar Amitabh Bachchan’s granddaughter Aaradhya Bachchan was born, is seeking its repossession from the...
covid 19: New COVID-19 treatment guidelines: Antibiotics only for bacterial infections, says Centre
A revised guideline for the treatment of adult COVID-19 patients has been issued by the Centre which advises against the use of antibiotics,...
vaidyaratnam: Vaidyaratnam Group plans to double revenue to Rs 500 cr, IPO by 2030
Thrissur-based ayurveda group Vaidyaratnam is looking at closing the current fiscal with a Rs 240 crore revenue and double the same by 2030...
